Clinical Center; Amended Notice of Meeting, 56993 [06-8329]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 188 / Thursday, September 28, 2006 / Notices
ESO–1/CAG–3-specific T cells to elicit
an anti-cancer immunogenic response
and thereby eliminating or reducing the
cancer. While these vaccines and
pharmaceutical compositions may be
developed for use against a variety of
cancers, data obtained to date indicate
that they may be of particular value for
use against melanoma.
Methods for diagnosing cancer via the
detection of NY ESO–1/CAG–3 are also
embodied in the invention.
Inventors: Steven A. Rosenberg (NCI)
et al.
Patent Status: U.S. Patent No.
7,084,239 issued 01 Aug 2006 (HHS
Reference No. E–265–1997/0–US–04).
Licensing Status: Available for nonexclusive licensing or exclusive
licensing.
Licensing Contact: Jesse S. Kindra,
J.D.; 301/435–5559;
kindraj@mail.nih.gov.
Dated: September 20, 2006.
Steven M. Ferguson,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. E6–15975 Filed 9–27–06; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Clinical Center; Amended Notice of
Meeting
sroberts on PROD1PC70 with NOTICES
Notice is hereby given of a change in
the meeting of the NIH Advisory Board
for Clinical Research, September 29,
2006, 10 a.m. to September 29, 2006, 2
p.m. National Institutes of Health,
Building 10, 10 Center Drive, 4–2551,
CRC Medical Board Room, Bethesda,
MD 20892 which was published in the
Federal Register on September 8, 2006,
FR 06–7534.
The open session will occur from 10
a.m.–1:30 p.m. The closed session will
begin approximately at 1:30 p.m. and
run until 2 p.m. The meeting will be
held in the Clinical Center, Bldg. 10,
Rm. 4–2551, CRC Medical Board Room.
The meeting is partially Closed to the
public.
Dated: September 19, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–8329 Filed 9–27–06; 8:45 am]
BILLING CODE 4140–01–M
VerDate Aug<31>2005
20:16 Sep 27, 2006
Jkt 208001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Alternative Medicine; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
application, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel; Basic Science.
Date: October 23–24, 2006.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Dale L. Birkle, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Center for
Complementary and Alternative Medicine,
NIH, 6707 Democracy Blvd., Suite 401,
Bethesda, MD 20892, (301) 451–6570,
birkled@mail.nih.gov.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel; Clinical Research.
Date: October 30–31, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Jeanette M. Hosseini, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Center for
Complementary and Alternative Medicine,
NIH, 6707 Democracy Blvd., Suite 401,
Bethesda, MD 20892, (301) 594–9096,
jeanetteh@mail.nih.gov.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel; Clinical Research
Huntington’s Disease.
Date: October 31, 2006.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Jeanette M. Hosseini, PhD,
Scientific Review Administrator, Office of
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
56993
Scientific Review, National Center for
Complementary and Alternative Medicine,
NIH, 6707 Democracy Blvd., Suite 401,
Bethesda, MD 20892, (301) 594–9096,
jeanetteh@mail.nih.gov.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel; Developmental
Centers for Research on CAM.
Date: November 16–17, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda, Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Martina Schmidt, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Center for
Complementary and Alternative Medicine,
NIH, 6707 Democracy Blvd., Suite 401,
Bethesda, MD 20892, (301) 594–3456,
schmidma@mail.nih.gov.
Dated: September 19, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–8328 Filed 9–27–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the contract
proposals, the disclosure of which
wouldconstitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Tropical Medicine Research
Centers.
Date: October 16–18, 2006.
Time: 8 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Gary S. Madonna, PhD,
Scientific Review Administrator, Scientific
Review Program, Division of Extramural
Activities, National Institutes of Health/
E:\FR\FM\28SEN1.SGM
28SEN1
]]>Agencies
[Federal Register Volume 71, Number 188 (Thursday, September 28, 2006)]
[Notices]
[Page 56993]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-8329]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Clinical Center; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the NIH
Advisory Board for Clinical Research, September 29, 2006, 10 a.m. to
September 29, 2006, 2 p.m. National Institutes of Health, Building 10,
10 Center Drive, 4-2551, CRC Medical Board Room, Bethesda, MD 20892
which was published in the Federal Register on September 8, 2006, FR
06-7534.
The open session will occur from 10 a.m.-1:30 p.m. The closed
session will begin approximately at 1:30 p.m. and run until 2 p.m. The
meeting will be held in the Clinical Center, Bldg. 10, Rm. 4-2551, CRC
Medical Board Room. The meeting is partially Closed to the public.
Dated: September 19, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-8329 Filed 9-27-06; 8:45 am]
BILLING CODE 4140-01-M
